Mol Med Rep. 2016 Feb;13(2):1373-80. doi: 10.3892/mmr.2015.4676. Epub 2015 Dec 11. 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). by Huang J1, Yang G2, Huang Y3, Kong W1, Zhang S2. Abstract Vitamin D, termed 1,25(OH)2D3 in it’s active form, activity is associated with a reduced risk of hepatocellular carcinoma (HCC) […]
read more